Yuri Ozaki

Yuri Ozaki

Auto-generated profile, based on publicly available information

Yuri Ozaki

Department of Breast Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 September 2019 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MTMitsuo Terada
Mitsuo Terada
AYAkiyo Yoshimura
Akiyo Yoshimura
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
GNGondo Naomi
Gondo Naomi
Hiroji IwataHiroji Iwata
Hiroji Iwata

19 February 2019 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MMMakiko Mori
Makiko Mori
KKKotani Kotani
Kotani Kotani
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
AYAkiyo Yoshimura
Akiyo Yoshimura
Hiroji IwataHiroji Iwata
Hiroji Iwata
Amyloid tumor of the breast is a rare disease, which was first reported in 1973. To date, only six cases have been reported in Japan. A 45-year-old woman who had a medical history of Sjogren’s syndrome presented with a lump of 3 cm in diameter on the outer side of the right breast. Mammography showed no abnormality. Ultrasonography showed a well-defined and rough hypoechoic mass of 32 mm in diameter at the site of the lump. With suspicion of breast cancer, an ultrasound-guided vacuum-assisted breast biopsy was performed. For pathological diagnosis, hematoxylin and eosin staining showed deposits of nonstructural substances in the interstitium. The specimen stained red with Congo red staining and showed green birefringence under a polarizing microscope. Thus, the mass was diagnosed as an amyloid tumor. Since the patient had Sjogren’s syndrome, it was considered a breast finding of autoimmune disease. We considered further therapy to be unnecessary, and annual follow-up was recommended. We diagnosed the mass as an amyloid tumor by an ultrasound-guided vacuum-assisted breast biopsy without resection. The patient had no systemic symptoms suspected systemic amyloidosis, and we diagnosed localized amyloidosis. An amyloid tumor of the breast may show findings suggestive of breast cancer. Pathological diagnosis before surgery is important to avoid excessive invasion. If deposits of nonstructural substances are observed by hematoxylin and eosin staining, Congo red staining should be added.

7 November 2018 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
NHNanae Horisawa
Nanae Horisawa
YAYayoi Adachi
Yayoi Adachi
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
AYAkiyo Yoshimura
Akiyo Yoshimura
Hiroji IwataHiroji Iwata
Hiroji Iwata
Radiation-associated angiosarcoma (RAAS) is a rare subtype of secondary angiosarcoma that is characterized by rapid proliferation and extensive tissue infiltration. Although various treatments for RAAS (such as surgery, chemotherapy, and radiation therapy) have been reported, there is no consensus as to which approach is the best. A 76-year-old woman presented with right breast cancer (T1N0M0, stage I) 9 years ago. She had undergone breast-conserving surgery and sentinel lymph node biopsy and was receiving adjuvant chemotherapy and radiation therapy for the malignancy. Six years after presenting with the tumor, she developed pigmented skin and was diagnosed with a RAAS; this angiosarcoma recurred three times within 2 years. The angiosarcoma was resected each of the three times, after which adjuvant radiation therapy was performed. At 76 years old, the patient developed a new mass on her chest skin in the vicinity of the scar. Angiosarcoma was diagnosed following a pathology report, which resulted in a second diagnosis of recurrent RAAS again since the diagnostic criteria were met. After extensive resection of the irradiated area, the patient has remained free of angiosarcoma for the last 3 years. Resection of the entire irradiated field is critical for successful treatment of RAAS.

10 May 2019 in Surgical Case Reports
Verified
Journal Article
Open access
PDF file
MTMitsuo Terada
Mitsuo Terada
NGNaomi Gondo
Naomi Gondo
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
AYAkiyo Yoshimura
Akiyo Yoshimura
Hiroji IwataHiroji Iwata
Hiroji Iwata
Giant cell tumor (GCT) of the breast is scarce. We report a case of GCT of the breast which was suspected as a malignant breast tumor. A 74-year-old woman noticed a tender lump in her right breast. We suspected a malignant tumor spreading widely with axillary lymph node metastasis on clinical examination and imaging. Histological evaluation of the biopsy tissue revealed a tumor composed the proliferation of oval to spindle-shaped cells and multinucleated giant cells without malignant epithelial cells. The tumor cells stained positively for CD68 and negatively for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. The pathological findings suggested GCT, and fine needle aspiration biopsy for the axillary lymph node was negative. However, there was a gap between the clinical presentation, such as a tender mass suggesting rapid growth and multiple lymphadenopathies, and the pathological presentation of biopsy, which made us hesitate to conclude GCT as the final preoperative diagnosis. We could not rule out the possibility of malignant tumors with OGCs before surgery. We performed mastectomy and sentinel lymph node biopsy according to a surgical procedure for node-negative breast cancer with a wide ductal spread. The resected tissue histologically showed the same findings to the biopsy tissue. The definitive diagnosis of GCT of the breast was given, because the tumor lacked epithelial components, marked cellular atypia, and pleomorphism. GCT of the breast occasionally pretends as breast malignant tumors. Complete tumor resection should be performed for local control and the definitive diagnosis.

27 July 2022 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
YEYuka Endo
Yuka Endo
AYAkiyo Yoshimura
Akiyo Yoshimura
MSMasataka Sawaki
Masataka Sawaki
MHMasaya Hattori
Masaya Hattori
KKKotani Kotani
Kotani Kotani
Hiroji IwataHiroji Iwata
Hiroji Iwata
Endo Y, et al. J Breast Cancer. 2022 Jul;25:e34. https://doi.org/10.4048/jbc.2022.25.e34